Original articleQuality of life and supportive careA randomized double-blind multicenter phase III study offixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy
Quality of life and supportive care
Under an Elsevier user license
open archive
Keywords
breast cancer
clinical trial
hemopoietic growth factor
multicenter study
neutropenia
Cited by (0)
- †
Additional members of the Pegfilgrastim 749 Study Group are listed in the acknowledgements.
Copyright © 2003 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.